Exact Mass: 312.1607

Exact Mass Matches: 312.1607

Found 113 metabolites which its exact mass value is equals to given mass value 312.1607, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1,3-Dipropyl-8-phenylxanthine

1,3-Dipropyl-8-phenylxanthine

C17H20N4O2 (312.1586)


   

Ethopropazine

N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine

C19H24N2S (312.166)


Ethopropazine is only found in individuals that have used or taken this drug.Ethopropazine (also known as profenamine hydrochloride) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism. It is sold under the trade names Parsidol in the United States and Parsidan in Canada.Ethopropazines antiparkinson action can be attributed to its anticholinergic properties. Ethopropazine partially blocks central (striatal) cholinergic receptors, thereby helping to balance cholinergic and dopaminergic activity in the basal ganglia; salivation may be decreased, and smooth muscle may be relaxed. Drug-induced extrapyramidal symptoms and those due to parkinsonism may be relieved, but tardive dyskinesia is not alleviated and may be aggravated by anticholinergic effects. Ethopropazines local anesthetic effect is due to its antagonism of the NMDA glutamate receptor. Glutamate is recognized as an important transmitter in nociceptive pathways, and the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, in particular, has been implicated in the mediation of neuropathic pain. Excessive release of glutamate at NMDA receptors on dorsal horn neurons of the spinal cord results in hyperactivation and hypersensitivity of these receptors (perceived as hyperalgesia), thought to be an integral feature of neuropathic pain. N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

Propamidine

4-[3-(4-carbamimidoylphenoxy)propoxy]benzene-1-carboximidamide

C17H20N4O2 (312.1586)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives

   

Thymol glucoside

Thymol-beta-D-glucoside

C16H24O6 (312.1573)


   

Pestalotheol A

Pestalotheol A

C16H24O6 (312.1573)


   

N-Methylviguine

N-Methylviguine

C19H22NO3+ (312.16)


   

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one

C17H20N4O2 (312.1586)


   

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone

C17H20N4O2 (312.1586)


   

THYMOL-B-D-GLUCOPYRANOSIDE

THYMOL-B-D-GLUCOPYRANOSIDE

C16H24O6 (312.1573)


   

Pyrenophorol

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

tetrahydropyrenophorin

tetrahydropyrenophorin

C16H24O6 (312.1573)


   

2-methyl-5-(1-methylethyl)phenyl beta-D-glucopyranoside|2-methyl-5-(1-methylethyl)phenyl-beta-D-glucopyranoside|carvacryl beta-D-glucopyranoside

2-methyl-5-(1-methylethyl)phenyl beta-D-glucopyranoside|2-methyl-5-(1-methylethyl)phenyl-beta-D-glucopyranoside|carvacryl beta-D-glucopyranoside

C16H24O6 (312.1573)


   
   

2,3,4-trimethylbenzyl alcohol-O-beta-D-glucopyranoside|2,3,4-trimethylbenzylalcohol-O-beta-D-glucopyranoside

2,3,4-trimethylbenzyl alcohol-O-beta-D-glucopyranoside|2,3,4-trimethylbenzylalcohol-O-beta-D-glucopyranoside

C16H24O6 (312.1573)


   

(R)-p-cymen-9-yl beta-glucopyranoside

(R)-p-cymen-9-yl beta-glucopyranoside

C16H24O6 (312.1573)


   

3alpha-Acetoxy-7-hydroxy-5beta-isobutyryloxy-carvotanacetone

3alpha-Acetoxy-7-hydroxy-5beta-isobutyryloxy-carvotanacetone

C16H24O6 (312.1573)


   

4,6-decadiyne-1-O-beta-D-glucopyranoside|carthamoside A2

4,6-decadiyne-1-O-beta-D-glucopyranoside|carthamoside A2

C16H24O6 (312.1573)


   

(3E,5S,8R,11E,13S,16R)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

NCGC00380335-01!(3E,5S,8R,11E,13S,16R)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

C16H24O6_beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

NCGC00380175-01_C16H24O6_beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

C16H24O6 (312.1573)


   

Thymol-beta-D-glucoside

Thymol-beta-D-glucoside

C16H24O6 (312.1573)


   

Minaprine,-lactame

Minaprine,-lactame

C17H20N4O2 (312.1586)


   

ethopropazine

Ethopropazine (oxide)

C19H24N2S (312.166)


   

Thymol-beta-D-glucoside_major

Thymol-beta-D-glucoside_major

C16H24O6 (312.1573)


   

Thymolglucoside

2-Isopropyl-5-methylphenyl ?-D-glucopyranoside

C16H24O6 (312.1573)


   

[4-(Dibenzylamino)phenyl]acetonitrile

[4-(Dibenzylamino)phenyl]acetonitrile

C22H20N2 (312.1626)


   

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate hydrochloride

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.1604)


   

Benzyl 2-butylpiperazine-1-carboxylate hydrochloride

Benzyl 2-butylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.1604)


   

4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]oxyaniline

4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]oxyaniline

C17H21BN2O3 (312.1645)


   

N,N-Dimethyl-1,1-binaphthalene-2,2-diamine

N,N-Dimethyl-1,1-binaphthalene-2,2-diamine

C22H20N2 (312.1626)


   

(R)-N,Nμ-Dimethyl-2,2μ-diamino-1,1μ-binaphthyl,(R)-N,Nμ-Dimethyl-1,1μ-binaphthalene-2,2μ-diamine

(R)-N,Nμ-Dimethyl-2,2μ-diamino-1,1μ-binaphthyl,(R)-N,Nμ-Dimethyl-1,1μ-binaphthalene-2,2μ-diamine

C22H20N2 (312.1626)


   

(S)-2-(tert-Butyldiphenylsilanyloxy)propionaldehyde

(S)-2-(tert-Butyldiphenylsilanyloxy)propionaldehyde

C19H24O2Si (312.1545)


   

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazol[5,1-f][1,2,4]-triazin-4-one

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazol[5,1-f][1,2,4]-triazin-4-one

C17H20N4O2 (312.1586)


   

3-hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropionate diacrylate

3-hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropionate diacrylate

C16H24O6 (312.1573)


   

2-(BENZYLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDINE

2-(BENZYLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDINE

C17H21BN2O3 (312.1645)


   

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoate

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoate

C18H21BO4 (312.1533)


   
   

(2H12)Coronene

(2H12)Coronene

C24D12 (312.1692)


   
   

MESO-1,2-BIS(1-NAPHTHYL)ETHYLENEDIAMINE

MESO-1,2-BIS(1-NAPHTHYL)ETHYLENEDIAMINE

C22H20N2 (312.1626)


   

(3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE

(3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE

C15H24N2O5 (312.1685)


   

2-Methyl-2-propanyl 7-(2-methoxy-2-oxoethyl)-6-oxo-1,7-diazaspiro [4.4]nonane-1-carboxylate

2-Methyl-2-propanyl 7-(2-methoxy-2-oxoethyl)-6-oxo-1,7-diazaspiro [4.4]nonane-1-carboxylate

C15H24N2O5 (312.1685)


   

methyl 2-(4-benzylpiperazin-1-yl)pyrimidine-5-carboxylate

methyl 2-(4-benzylpiperazin-1-yl)pyrimidine-5-carboxylate

C17H20N4O2 (312.1586)


   

Tofacitinib

Tofacitinib

C16H20N6O (312.1699)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors > D000075242 - Janus Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]-5-oxopyrrolidine-3-carboxylic acid

1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]-5-oxopyrrolidine-3-carboxylic acid

C15H24N2O5 (312.1685)


   

[1,1-Binaphthalene]-2,2-diamine, N,N-dimethyl

[1,1-Binaphthalene]-2,2-diamine, N,N-dimethyl

C22H20N2 (312.1626)


   

Benzo-18-crown-6

Benzo-18-crown-6

C16H24O6 (312.1573)


   

(3R,4S)-Tofacitinib

(3R,4S)-Tofacitinib

C16H20N6O (312.1699)


   

(3S,4S)-Tofacitinib

(3S,4S)-Tofacitinib

C16H20N6O (312.1699)


   

(3S,4R)-Tofacitinib

(3S,4R)-Tofacitinib

C16H20N6O (312.1699)


   

benzyl (2R)-2-butylpiperazine-1-carboxylate,hydrochloride

benzyl (2R)-2-butylpiperazine-1-carboxylate,hydrochloride

C16H25ClN2O2 (312.1604)


   

Molindone hydrochloride

(±)-Molindone Hydrochloride

C16H25ClN2O2 (312.1604)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Molindone hydrochloride (EN-1733A) is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.

   

4-(PHENYLTHIO)OCTANOPHENONE

4-(PHENYLTHIO)OCTANOPHENONE

C20H24OS (312.1548)


   

Olanzapine Lactam Impurity

Olanzapine Lactam Impurity

C17H20N4O2 (312.1586)


   

Anastrozole Mono Acid

Anastrozole Mono Acid

C17H20N4O2 (312.1586)


   

4-(2,3-Difluoro-5-Methyl-phenyl)-piperazine-1-carboxylic acid tert-butyl ester

4-(2,3-Difluoro-5-Methyl-phenyl)-piperazine-1-carboxylic acid tert-butyl ester

C16H22F2N2O2 (312.1649)


   

trans-4-(Benzyloxycarbonylamino)cyclohexanemethylamine hydrochloride

trans-4-(Benzyloxycarbonylamino)cyclohexanemethylamine hydrochloride

C16H25ClN2O2 (312.1604)


   

Amides,coco, N-[3-(dimethylamino)propyl]

5-[3-(2,5-Dimethoxyphenyl)prop-1-Yn-1-Yl]-6-Ethylpyrimidine-2,4-Diamine

C17H20N4O2 (312.1586)


   

4-Chloro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

4-Chloro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

C21H25Cl (312.1645)


   

(R)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

(R)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.1604)


   

(S)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

(S)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.1604)


   

methyl (3s,6s,8ar)-6-[(tert-butoxycarbonyl)amino]-5-oxooctahydroindolizine-3-carboxylate

methyl (3s,6s,8ar)-6-[(tert-butoxycarbonyl)amino]-5-oxooctahydroindolizine-3-carboxylate

C15H24N2O5 (312.1685)


   

4-(4-amino-3-methylnaphthalen-1-yl)-2-methylnaphthalen-1-amine

4-(4-amino-3-methylnaphthalen-1-yl)-2-methylnaphthalen-1-amine

C22H20N2 (312.1626)


   

(R)-1-N-BOC-2-BENZYLPIPERAZINE-HCl

(R)-1-N-BOC-2-BENZYLPIPERAZINE-HCl

C16H25ClN2O2 (312.1604)


   

(S)-1-N-BOC-2-BENZYL-PIPERAZINE-HCl

(S)-1-N-BOC-2-BENZYL-PIPERAZINE-HCl

C16H25ClN2O2 (312.1604)


   

benzyl (2S)-2-butylpiperazine-1-carboxylate,hydrochloride

benzyl (2S)-2-butylpiperazine-1-carboxylate,hydrochloride

C16H25ClN2O2 (312.1604)


   

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

C16H24O6 (312.1573)


   

(+)-Ethopropazine

(+)-Ethopropazine

C19H24N2S (312.166)


   

(S)-ethopropazine

(S)-ethopropazine

C19H24N2S (312.166)


   

N-[2-[(3-cyano-6-ethoxy-2-quinolinyl)amino]ethyl]propanamide

N-[2-[(3-cyano-6-ethoxy-2-quinolinyl)amino]ethyl]propanamide

C17H20N4O2 (312.1586)


   

1,2-Diphenyltryptamine

1,2-Diphenyltryptamine

C22H20N2 (312.1626)


   

6,7,8,13,14,15-Hexahydro-7,14-methanobenzo[6,7]cyclodeca[1,2-b]naphthalen-17-one

6,7,8,13,14,15-Hexahydro-7,14-methanobenzo[6,7]cyclodeca[1,2-b]naphthalen-17-one

C23H20O (312.1514)


   

Profenamine

ethopropazine

C19H24N2S (312.166)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

propamidine

propamidine

C17H20N4O2 (312.1586)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives

   

Glucopyranoside,2-ipr-5-ME phenyl

Glucopyranoside,2-ipr-5-ME phenyl

C16H24O6 (312.1573)


   

Thebaine(1+)

Thebaine(1+)

C19H22NO3+ (312.16)


The trialkylammonium ion resulting from the protonation of the amino group of thebaine.

   

beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

C16H24O6 (312.1573)


   

(2S,3E)-4-[(4aR,5aS,9R,10aR,11S,11aS)-11-hydroxy-2,3,4,4a,5a,6,9,10a,11,11a-decahydropyrano[2,3:5,6]pyrano[3,2-b]oxepin-9-yl]but-3-ene-1,2-diol

(2S,3E)-4-[(4aR,5aS,9R,10aR,11S,11aS)-11-hydroxy-2,3,4,4a,5a,6,9,10a,11,11a-decahydropyrano[2,3:5,6]pyrano[3,2-b]oxepin-9-yl]but-3-ene-1,2-diol

C16H24O6 (312.1573)


   

1-{4-[(2-Hydroxyethyl)carbamoyl]benzyl}-1-methylpiperidinium chloride

1-{4-[(2-Hydroxyethyl)carbamoyl]benzyl}-1-methylpiperidinium chloride

C16H25ClN2O2 (312.1604)


   

6-(4-Phenylpiperazino)hexanoic acid hydrochloride

6-(4-Phenylpiperazino)hexanoic acid hydrochloride

C16H25ClN2O2 (312.1604)


   

3-[(2-Oxo)-2-morpholinoethylamino]-4-methyl-6-phenylpyridazine

3-[(2-Oxo)-2-morpholinoethylamino]-4-methyl-6-phenylpyridazine

C17H20N4O2 (312.1586)


   

Isopropyl 2-(N-((4S)-4-(1-methylethyl)-2-oxazolidinone-3-carbamoyl)amino)-4-pentenoate

Isopropyl 2-(N-((4S)-4-(1-methylethyl)-2-oxazolidinone-3-carbamoyl)amino)-4-pentenoate

C15H24N2O5 (312.1685)


   

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

RSVA405

RSVA405

C17H20N4O2 (312.1586)


RSVA405 is a potent, orally active activator of AMPK, with an EC50 of 1 μM. RSVA405 facilitates CaMKKβ-dependent activation of AMPK, inhibits mTOR, and promotes autophagy to increase Aβ degradation. RSVA405 has anti-inflammatory effects through the inhibition of STAT3 function. RSVA405 can also be used for the research of obesity[1][2][3][4].

   

n-hexyl-2-hydroxy-n-[3-(2-oxo-5h-furan-3-yl)propanoyl]ethanehydrazonic acid

n-hexyl-2-hydroxy-n-[3-(2-oxo-5h-furan-3-yl)propanoyl]ethanehydrazonic acid

C15H24N2O5 (312.1685)


   

(3s,5r,7s,8r)-7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

(3s,5r,7s,8r)-7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

C16H24O6 (312.1573)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

C16H24O6 (312.1573)


   

(3z,5s,11e,13r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

(3z,5s,11e,13r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

2-(hydroxymethyl)-6-[2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

C16H24O6 (312.1573)


   

7-hydroxy-7-(6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl)heptanoic acid

7-hydroxy-7-(6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl)heptanoic acid

C16H24O6 (312.1573)


   

(8r,13r,16r)-13-hydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione

(8r,13r,16r)-13-hydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione

C16H24O6 (312.1573)


   

6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

[C19H22NO3]+ (312.16)


   

(9s)-3,4-dihydroxy-16-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-10-ium

(9s)-3,4-dihydroxy-16-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-10-ium

[C19H22NO3]+ (312.16)


   

(3r,3as,5ar,9as,9bs)-3-(methoxymethyl)-5a-methyl-octahydro-3h-spiro[naphtho[1,2-b]furan-9,2'-[1,3,4]trioxolan]-2-one

(3r,3as,5ar,9as,9bs)-3-(methoxymethyl)-5a-methyl-octahydro-3h-spiro[naphtho[1,2-b]furan-9,2'-[1,3,4]trioxolan]-2-one

C16H24O6 (312.1573)


   

(1s,2r,4s,5r,6s,9s,10s,11r,12s,13r)-2,4,11-trihydroxy-2,6,11,12-tetramethyl-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-7-one

(1s,2r,4s,5r,6s,9s,10s,11r,12s,13r)-2,4,11-trihydroxy-2,6,11,12-tetramethyl-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-7-one

C16H24O6 (312.1573)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r)-2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r)-2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

C16H24O6 (312.1573)


   

(5r,8r,13s,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

(5r,8r,13s,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

C16H24O6 (312.1573)


   

4-hydroxy-4-{3-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-2-methyloxiran-2-yl}-5-methoxy-1-oxaspiro[2.5]octan-6-one

4-hydroxy-4-{3-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-2-methyloxiran-2-yl}-5-methoxy-1-oxaspiro[2.5]octan-6-one

C16H24O6 (312.1573)


   

(3e,5r,8s,11e,13r,16s)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

(3e,5r,8s,11e,13r,16s)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

methyl 2-[5-methoxy-4-(3-oxobutan-2-yl)-4,5-dihydrofuran-3-carbonyl]-2-methylbutanoate

methyl 2-[5-methoxy-4-(3-oxobutan-2-yl)-4,5-dihydrofuran-3-carbonyl]-2-methylbutanoate

C16H24O6 (312.1573)


   

(6s)-6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

(6s)-6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

[C19H22NO3]+ (312.16)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)oxane-3,4,5-triol

C16H24O6 (312.1573)


   

(5r,8r,13r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

(5r,8r,13r,16r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

2-(hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)oxane-3,4,5-triol

2-(hydroxymethyl)-6-(2-isopropyl-5-methylphenoxy)oxane-3,4,5-triol

C16H24O6 (312.1573)


   

(7s)-7-hydroxy-7-[(2s,6s)-6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl]heptanoic acid

(7s)-7-hydroxy-7-[(2s,6s)-6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl]heptanoic acid

C16H24O6 (312.1573)


   

(5as,6r,9s,9as)-9-hydroxy-6-isopropyl-9-(methoxymethyl)-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

(5as,6r,9s,9as)-9-hydroxy-6-isopropyl-9-(methoxymethyl)-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

C16H24O6 (312.1573)


   

(1e,3r,4r,5r,6s)-1-[2-(hydroxymethyl)-3-methoxyphenyl]-6-methoxyhept-1-ene-3,4,5-triol

(1e,3r,4r,5r,6s)-1-[2-(hydroxymethyl)-3-methoxyphenyl]-6-methoxyhept-1-ene-3,4,5-triol

C16H24O6 (312.1573)


   

1-[2-(hydroxymethyl)-3-methoxyphenyl]-6-methoxyhept-1-ene-3,4,5-triol

1-[2-(hydroxymethyl)-3-methoxyphenyl]-6-methoxyhept-1-ene-3,4,5-triol

C16H24O6 (312.1573)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)oxane-3,4,5-triol

C16H24O6 (312.1573)


   

(5r,8r,16r)-5,14-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

(5r,8r,16r)-5,14-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1573)


   

7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

C16H24O6 (312.1573)


   

methyl 2-[(4s,5s)-5-methoxy-4-(3-oxobutan-2-yl)-4,5-dihydrofuran-3-carbonyl]-2-methylbutanoate

methyl 2-[(4s,5s)-5-methoxy-4-(3-oxobutan-2-yl)-4,5-dihydrofuran-3-carbonyl]-2-methylbutanoate

C16H24O6 (312.1573)